McKesson (MCK)
(Real Time Quote from BATS)
$477.26 USD
-3.23 (-0.67%)
Updated Sep 25, 2024 02:11 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Company Summary
San Francisco, CA-based McKesson Corporation is a health care services and information technology company. McKesson operates through two segments:
The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare ...
Company Summary
San Francisco, CA-based McKesson Corporation is a health care services and information technology company. McKesson operates through two segments:
The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers within the U.S.
The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions.
In the fourth quarter of fiscal 2022, per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Notably, McKesson’s role in the COVID-19 response was reflected in the collaboration with the U.S. government's COVID-19 vaccine distribution effort, wherein McKesson was selected as the centralized distributor of refrigerated and frozen COVID-19 vaccines and the ancillary kits used to administer those vaccines.
FY24 at a Glance
Revenues in fiscal 2024 grossed $309 billion, up 12% from the year-ago period. U.S. Pharmaceutical and Specialty Solutions (87% of net revenues), International (7.4%), Medical-Surgical Solutions (4%) and Prescription Technology Solutions (1.6%). Adjusted EPS for fiscal 2024 was $27.44, up 6% year over year.
General Information
McKesson Corporation
6555 STATE HWY 161
IRVING, TX 75039
Phone: 972-446-4800
Fax: 415-983-8453
Email: investors@mckesson.com
Industry | Medical - Dental Supplies |
Sector | Medical |
Fiscal Year End | March |
Last Reported Quarter | 6/30/2024 |
Earnings Date | 11/6/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 7.09 |
Current Year EPS Consensus Estimate | 32.07 |
Estimated Long-Term EPS Growth Rate | 13.40 |
Earnings Date | 11/6/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 480.49 |
52 Week High | 637.51 |
52 Week Low | 431.35 |
Beta | 0.44 |
20 Day Moving Average | 1,198,400.50 |
Target Price Consensus | 617.07 |
4 Week | -12.75 |
12 Week | -17.84 |
YTD | 3.78 |
4 Week | -14.38 |
12 Week | -21.05 |
YTD | -13.65 |
Shares Outstanding (millions) | 129.68 |
Market Capitalization (millions) | 62,308.38 |
Short Ratio | NA |
Last Split Date | 1/5/1998 |
Dividend Yield | 0.59% |
Annual Dividend | $2.84 |
Payout Ratio | 0.09 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | 8/30/2024 / $0.71 |
Fundamental Ratios
P/E (F1) | 14.98 |
Trailing 12 Months | 17.14 |
PEG Ratio | 1.12 |
vs. Previous Year | 8.39% |
vs. Previous Quarter | 27.51% |
vs. Previous Year | 6.44% |
vs. Previous Quarter | 3.83% |
Price/Book | NA |
Price/Cash Flow | 14.64 |
Price / Sales | 0.20 |
6/30/24 | -242.57 |
3/31/24 | -245.88 |
12/31/23 | -262.63 |
6/30/24 | 5.47 |
3/31/24 | 5.57 |
12/31/23 | 5.96 |
6/30/24 | 0.93 |
3/31/24 | 0.92 |
12/31/23 | 0.92 |
6/30/24 | 0.47 |
3/31/24 | 0.51 |
12/31/23 | 0.50 |
6/30/24 | 1.18 |
3/31/24 | 1.19 |
12/31/23 | 1.28 |
6/30/24 | 0.94 |
3/31/24 | 0.97 |
12/31/23 | 0.99 |
6/30/24 | 1.21 |
3/31/24 | 1.23 |
12/31/23 | 1.18 |
6/30/24 | -10.65 |
3/31/24 | -12.17 |
12/31/23 | -12.80 |
6/30/24 | 13.27 |
3/31/24 | 13.84 |
12/31/23 | 13.74 |
6/30/24 | NA |
3/31/24 | NA |
12/31/23 | NA |
6/30/24 | NA |
3/31/24 | NA |
12/31/23 | NA |